GWM
DMAC icon

GK Wealth Management’s DiaMedica Therapeutics DMAC Stock Holding History

GK Wealth Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.2K Buy
+2,810
New +$19.6K 0.01% 626

Other funds holding DMAC

Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GK Wealth Management's DMAC Position: Q3 2026 in Review

GK Wealth Management opened a new position in DiaMedica Therapeutics (DMAC) in Q3 2026: 2,810 shares worth $23.2K. The stake represents 0.01% of the portfolio and ranks #626 among its holdings.

6 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.

  • GK Wealth Management held 2,810 shares of DiaMedica Therapeutics worth $23.2K as of Q3 2026.
  • DiaMedica Therapeutics was a new GK Wealth Management position in Q3 2026.
  • DiaMedica Therapeutics made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #626 holding.
  • 6 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.